Palliative care and symptom-based management play a central role in the care of patients with neurologic disease. With daily frequency, neurologists diagnose and treat patients with life-threatening, life-limiting, or significantly life-altering disease. It is, therefore, surprising that such a pervasive theme is inadequately addressed during neurology residency training.1 The purpose of this study was to assess the basic palliative care (PC) knowledge of neurology residents throughout the country.
A 5-question survey was developed that included questions regarding the major clinical topics of PC (Table). From November 2007 to March 2008, program directors from all Accreditation Council for Graduate Medical Education–certified neurology residency programs were contacted and voluntary/anonymous resident participation requested. After receiving approval from our institutional review board, the survey was mailed to participating programs and given during teaching conferences at approximately the same time to reduce cross-communication. Participants were asked to refrain from discussion or reference materials while responding.
Our primary outcome measure was the percentage of questions correctly answered. Logistic regression was used to assess the correlation between a correct answer and amount of training (program year and months of PC training). Each training function was modeled both as continuous linear variables and categorical variables. Two-sided P values from regression models were derived from the Wald test; no adjustments were made for multiple comparisons.
Thirty-four neurology programs agreed to participate, and 338 questionnaires were returned. This corresponds to one-third of neurology programs and one-fifth of neurology residents in the United States. Only 9 of the participants were first-year residents; there was an even distribution of second-, third-, and fourth-year residents (100, 108, and 100 residents, respectively); 9 participants were in their fifth year (fellows); 2 had been in neurology training for more than 6 years; and 4 did not indicate their year of training.
Palliative care training (PCT) was assessed for the number of months in care. Most participants (n = 181) had no PCT, and another 80 declined to provide their amount of PCT. The maximum times spent in PCT were 20 months in 1 case and 12 months in 3 cases. One program with 6 participants reported that their 2 youngest (second-year) residents had no PC experience, while all older residents had one-fourth of a month of PCT, suggesting this was an inherent part of their program. The 77 residents who reported having PCT were dispersed among 28 of 34 participating programs (82%).
The overall mean knowledge score was 44%. Residents scored the highest on the question relating to advanced directives and were least knowledgeable about pharmacology (Table). There is insufficient evidence from the regression models to suggest that months of training in PC or year of residency will predict whether a resident will answer any question correctly.
Prior efforts7,8 to improve the quality of PC training in Accreditation Council for Graduate Medical Education–certified residency programs have met with minimal enthusiasm and little visible change to the status quo. According to neurology residency program directors, only 52% of programs offer a didactic experience in end-of-life and/or palliative care, and fewer than 8% provide clinical rotation.9 Our study showed no correlation between program and PCT, suggesting that PCT is rarely a compulsory part of a program's curriculum.
Recently, the American Board of Psychiatry and Neurology took a bold step in offering the Initial Certification in the Subspecialty of Hospice and Palliative Medicine. While this advanced training will motivate some physicians to address PC in the neurologic setting, it does little to train the vast majority of graduating residents. The results of this preliminary study support earlier studies10,11 and confirm the dire need to enhance PC education of neurology resident physicians, who play a vital role in the care of patients faced with a life-threatening, life-limiting, and/or life-changing disease.
Correspondence: Dr Creutzfeldt, Department of Neurology, University of Washington, Harborview Medical Center, Box 359775, 325 Ninth Ave, Seattle, WA 98104-2420 (email@example.com).
Author Contributions: All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Creutzfeldt and Walker. Acquisition of data: Creutzfeldt and Walker. Analysis and interpretation of data: Creutzfeldt, Gooley, and Walker. Drafting of the manuscript: Creutzfeldt and Walker. Critical revision of the manuscript for important intellectual content: Creutzfeldt, Gooley, and Walker. Statistical analysis: Gooley. Administrative, technical, and material support: Creutzfeldt and Walker. Study supervision: Creutzfeldt and Walker.
Financial Disclosure: None reported.
This article was corrected online for typographical errors on 11/9/2009.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Neurology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.